Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05251974 · ClinicalTrials.gov registry record
Assay to Measure Beta Blocker Adherence
A clinical trial, sponsored by Summa Health System.
- Terminated
- Registry status
- 27
- Enrollment target
NCT05251974 is a clinical trial that was terminated before completion, run by Summa Health System. The registered enrollment target is 27 participants.
The verdict
NCT05251974 was terminated before completion, sponsored by Summa Health System.
- TERMINATED
- Registry status
- 27 participants
- Enrollment target
Study Summary
This study will assess the feasibility and efficacy of using serum assay developed by Quest Diagnostics to detect the presence of beta blockers, specifically carvedilol and metoprolol succinate, in patients with heart failure.
Interventions
- DIAGNOSTIC_TEST Quest beta blocker assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2022-03-02 |
| Est. Completion | 2023-11-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05251974
The ClinicalTrials.gov registry entry for NCT05251974 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Summa Health System, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quest beta blocker assay is the first listed.
NCT05251974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05251974 about?
NCT05251974 is a clinical study titled "Assay to Measure Beta Blocker Adherence". This study will assess the feasibility and efficacy of using serum assay developed by Quest Diagnostics to detect the presence of beta blockers, specifically carvedilol and metoprolol succinate, in patients with heart failure.
What is the current status of trial NCT05251974?
This trial is currently terminated. The enrollment target is 27 participants. The study started on 2022-03-02. Estimated completion is 2023-11-15.
What interventions are being tested in trial NCT05251974?
The interventions under investigation include: Quest beta blocker assay (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05251974?
This trial is sponsored by Summa Health System, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.